ARCHIVES

Impact Of DRGs On Clinical Research Less Than First Feared, Speakers Tell NIH Directors Meeting

This article is from The Cancer Letter archive.

Vol. 12 No. 25 | June 20, 1986

Download PDF Visit The Full Archive

Related Articles

President’s Budget Asks $1.646 Billion for NCI In FY 1990, Including AIDS, 3% Increase Over ‘89

January 13, 1989

FDA Begins To Examine Its Role In Allowing Misleading Consumer Advertising.

May 18, 2007

H. Lee Moffitt Center Reads The Cancer Letter

July 19, 2002

Zaltrap Receives Positive Opinion For European Market From CHMP

November 30, 2012

Cancer Patients Satisfied With Experience In Clinical Trials, Survey Of 2,000 Finds

July 28, 2006

In Brief: Daniel Ihde Named NCI Deputy Director; Roper Is Carter consultant; Another Honor For Forei

February 8, 1991